MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Pulmonx touts new coverage for Zephyr valve

August 28, 2019 By Sean Whooley Leave a Comment

Pulmonx said today that its Zephyr valve designed to treat chronic respiratory disease is now covered by Priority Health under a revised lung volume reduction policy. Redwood City, Calif.-based Pulmonx’s Zephyr valves are designed to provide a less-invasive treatment option for emphysema and chronic obstructive pulmonary disease by blocking off the diseased area of the […]

Filed Under: Business/Financial News, Respiratory Tagged With: Pulmonx

The 17 most innovative medical devices of 2019

July 18, 2019 By Danielle Kirsh Leave a Comment

The Galien Foundation recently announced nominees for most innovative medical devices for its 13th Annual Prix Galien USA Awards. The foundation awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Nominees need to be FDA approved for market within the last five […]

Filed Under: Cardiac Implants, Cardiovascular, Drug-Device Combinations, Featured, Implants, Neuromodulation/Neurostimulation, News Well, Research & Development, Stents Tagged With: Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Endomagnetics, Glaukos, humanoptics, Lynch Biologics, Medtronic, Pear Therapeutics, Pulmonx, Sonendo, starkey, Teva Pharmaceuticals

Pulmonx raises $65m, taps Sung as CFO

May 9, 2019 By Fink Densford Leave a Comment

Pulmonx said today that it raised $65 million in an oversubscribed equity round and added that it picked up Derrick Sung as its new chief financial officer. Funding in the round was lead by Ally Bridge Group and joined by newly invested RTW Investments, ArrowMark Partners, Driehaus Capital Management and existing investors, the Redwood City, […]

Filed Under: Business/Financial News, Featured, Respiratory, Wall Street Beat Tagged With: Pulmonx

Pulmonx wins Aetna coverage for Zephyr endobronchial valve

November 15, 2018 By Fink Densford Leave a Comment

Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder. The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said. Under its new policy, Aetna specifically named the […]

Filed Under: Business/Financial News, Respiratory Tagged With: Pulmonx

Pulmonx wins FDA approval for Zephyr endobronchial valve

June 29, 2018 By Brad Perriello Leave a Comment

The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema. Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The […]

Filed Under: Endoscopic, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: Pulmonx

Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study

May 23, 2018 By Fink Densford Leave a Comment

Pulmonx yesterday released one-year results from the pivotal trial of its Zephyr endobronchial valve designed to treat patients with severe emphysema from chronic obstructive pulmonary disease, touting significant improvements in lung function and quality of life. Results from the study were presented at the American Thoracic Society 2018 international conference and published in the American Journal […]

Filed Under: Clinical Trials, Respiratory Tagged With: Pulmonx

These medtech companies raised the most VC last year

January 19, 2018 By Danielle Kirsh Leave a Comment

Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]

Filed Under: Cardiovascular, Digital Health, Funding Roundup, Hospital Care, Implants Tagged With: Auris Surgical Robotics, Cereve, EarLens, Ebb Therapeutics, EBR Systems Inc., Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Fractyl Laboratories, immusant, MedTech, Moximed, NeuroPace, Outset Medical, Pulmonx, Respicardia, rxsight, Silk Road Medical Inc., venture capital, VertiFlex Inc., Xenex

British health agency backs endobronchial valves from Pulmonx, OIympus

December 21, 2017 By Brad Perriello Leave a Comment

Pulmonx and Olympus (TYO:7733) won a nod from a British health agency for the endobronchial valves they sell to treat severe emphysema. The U.K.’s National Institute for Health & Care Excellence updated its guidance for the valves, saying it considers the clinical evidence behind them sufficient to support routine use. The one-way valves, Pulmonx’s Zephyr and the Spiration […]

Filed Under: Respiratory Tagged With: Olympus, Pulmonx, U.K. National Institute for Health & Care Excellence (NICE)

Pulmonx touts Chartis, Zephyr combo-treatment study

December 10, 2015 By Fink Densford Leave a Comment

Pulmonx said today data from the Stelvio trial of its Chartis system and Zephyr endobronchial valve demonstrated statistically and clinically significant outcomes in lung function, exercise capacity and quality of life in severe emphysema patients. Data from the study was published today in the New England Journal of Medicine. “When we select patients with the […]

Filed Under: Clinical Trials, Respiratory Tagged With: Pulmonx

Pulmonx touts sham trial data

July 13, 2015 By Fink Densford Leave a Comment

Pulmonx said earlier this month that a sham-controlled trial of its Zephyr endobronchial valve met and exceeded its primary endpoints, reporting a 20.9% average improvement in lung function. The Believer-Hifi study, published in The Lancet, is the 1st successful sham-controlled trial of any invasive emphysema device, Redwood City, Calif.-based Pulmonx said. “We have been able […]

Filed Under: Clinical Trials, Respiratory Tagged With: Pulmonx

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

December 19, 2014 By Brad Perriello Leave a Comment

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.

Filed Under: News Well Tagged With: AdvaMed, Aloka Co., Asthmatx Inc., becton dickinson, Boston Scientific, Mayo Clinic, milestonescientific, NxStage Medical Inc., Personnel Moves, Pulmonx, Quest Diagnostics Inc., ResMed Inc., ReWalk Robotics, RTI Surgical, Zimmer Biomet

  • 1
  • 2
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS